Oncology Institute (TOI) Leases (2022 - 2025)
Oncology Institute (TOI) has disclosed Leases for 4 consecutive years, with $23.3 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Leases fell 14.1% year-over-year to $23.3 million, compared with a TTM value of $23.3 million through Sep 2025, down 14.1%, and an annual FY2024 reading of $25.8 million, down 11.61% over the prior year.
- Leases was $23.3 million for Q3 2025 at Oncology Institute, down from $23.9 million in the prior quarter.
- Across five years, Leases topped out at $29.2 million in Q4 2023 and bottomed at $17.2 million in Q1 2022.
- Average Leases over 4 years is $24.9 million, with a median of $24.8 million recorded in 2022.
- The sharpest move saw Leases skyrocketed 68.3% in 2023, then fell 14.1% in 2025.
- Year by year, Leases stood at $24.5 million in 2022, then grew by 19.09% to $29.2 million in 2023, then dropped by 11.61% to $25.8 million in 2024, then dropped by 9.76% to $23.3 million in 2025.
- Business Quant data shows Leases for TOI at $23.3 million in Q3 2025, $23.9 million in Q2 2025, and $24.2 million in Q1 2025.